阻断性喘治疗的干预性肺病学技术背后的一个潜在机制:神经免疫交叉通话
Ximing Liao1, Shaoyong Gao1, Fengyang Xie2
1Department of Respiratory and Critical Care Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Heliyon
|October 23, 2023
概括
干预性肺病学技术,如支气管热塑术,提供了新的耐火性喘治疗方法. 通过双神经切除来阻止神经免疫交叉声可能是它们有效性的关键.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
背景情况:
- 喘是一种常见的呼吸道疾病,对公共健康有重大影响.
- 干预性肺病学为耐火性喘管理提供了新的技术.
- 了解这些治疗方法的机制和共同点至关重要.
研究的目的:
- 审查和比较支气管热塑性术,向性肺缩和喘冷的机制.
- 探索这些干预技术之间的关系和共同点.
- 假设干预性肺病学在喘中的疗效的潜在途径.
主要方法:
- 对喘的干预性肺病学技术的文献综述.
- 分析机理,包括支气管热塑,向肺部脱皮和冷.
- 在喘病理生理学中探索神经免疫相互作用.
主要成果:
- 这些技术针对各种喘病理生理学方面.
- 一个中心途径涉及与感觉神经相关的神经递质的释放,创造"神经免疫交叉声".
- 这种交叉声会放大气道的神经性炎症.
结论:
- 干预性肺病学在耐火性喘中显示出临床效应.
- 阻断神经免疫交叉声,特别是通过对 afferent 和 efferent 神经纤维的双重切除,是一个潜在的领导机制.
- 为了优化喘治疗,需要对这种双除机制进行进一步的研究.
更多相关视频
相关概念视频
Asthma: Pathogenesis and Management
421
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
421
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Drugs Used in Lower Respiratory Disorders: Overview
458
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
458
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
312
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
312
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K


